The Hemoglobin Level as a Prognostic Factor in Patients with Non-Small Cell Lung Cancer Treated with Gemcitabine and cis-Platinum
Journal Title: Journal of IMAB - Annual Proceeding (Scientific Papers) - Year 2012, Vol 18, Issue 1
Abstract
Objective: Anemia is observed in various malignancies including non- small cell lung cancer /NSCLC/ and is considered to be a poor prognostic factor. The aim of this study is to investigate whether there is a correlation between anemia, other clinic- pathological factors and survival in patients with advanced NSCLC treated with Gemcitabine / cis- Platinum- containing chemotherapy. Methods: Seventy eight consecutive patients with advanced NSCLC treated in Department of Chemotherapy, UMHAT - Dr. G. Stranski, Medical University - Pleven between 2006-2008 were retrospectively analyzed. Of those, 27 patients /34, 6%/ had low hemoglobin /HB/ level (<120g/L for men and <110g/L for women) prior to start chemotherapy. The HB levels were obtained at the time of their first visit to the hospital. All patients received chemotherapy regimen consists of intravenous administration of Gemcitabine 1250 mg/m2 day 1 and 8 and cis- Platinum 80mg/m2 day 1 with repetition over 21 days. Survival analysis was evaluated by Kaplan- Meier test. Results: The median survival time for all patients was 9,5 months. The median survival time for patients with low HB levels was 7,6 months versus 11,3 months in patients without anemia /p<0.05/. There was a significant correlation between anemia and clinical stage or performance status /p<0.05/. Conclusions: These results indicate that patients without anemia have significantly higher survival rate. Pretreatment HB level appears to be a useful prognostic indicator for survival in patients with inoperable NSCLC treated with chemotherapy.
Authors and Affiliations
Deyan Davidov
Keywords
Related Articles
- EP ID EP124904
- DOI 10.5272/jimab.2012181.209
- Views 107
- Downloads 0
ORGANIZATIONAL STRUCTURE OF RESEARCH PROJECT ACTIVITIES PERFORMED AT MEDICAL UNIVERSITIES IN BULGARIA
Introduction: There are five Bulgarian medical universities in the cities of Sofia, Plovdiv, Varna, Pleven and Stara Zagora. A major priority of medical universities is to encourage research activities mainly aimed at pr...
SOME PHARMACOLOGIC TREATMENT OPTIONS IN LATER- LIFE ANXIETY DISORDERS
Most recommendations for treatment of anxiety in later life are based on evidence, derived from studies of younger populations. An important challenge is the high psychic and physical comorbidity of primary anxiety...
INTRAOPERATIVE ULTRASOUND EXAMINATION OF HILAR CHOLANGIOCARCINOMA /TUMOR OF KLATSKIN /
Purpose: To compare the opportunities of the intraoperative ultrasound examination of the liver with the preoperative imaging methods – Computer tomography (CT), Ultrasound examination (US) in detecting hepatic lesions...
IDIOPATHIC INTRACRANIAL HYPERTENSION IN A WOMAN WITH SCHIZOPHRENIA
Idiopathic intracranial hypertension (IIH) or benign intracranial hypertension is a neurological syndrome characterized by elevated intracranial pressure. This uncommon disorder occurs primarily in obese women aged 10 to...
AWARENESS OF DENTISTS ABOUT ORAL HEALTH OF CHILDREN WITH DISABILITIES.
Introduction: Children with disabilities are a unique group with impaired ability to cater for their own oral health and are in greater need of procedures for the prevention of oral diseases, due to the higher risk...